THE CLINICAL SPECTRUM OF OCULAR LYMPHOMA

Citation
K. Peterson et al., THE CLINICAL SPECTRUM OF OCULAR LYMPHOMA, Cancer, 72(3), 1993, pp. 843-849
Citations number
32
Categorie Soggetti
Oncology
Journal title
CancerACNP
ISSN journal
0008543X
Volume
72
Issue
3
Year of publication
1993
Pages
843 - 849
Database
ISI
SICI code
0008-543X(1993)72:3<843:TCSOOL>2.0.ZU;2-3
Abstract
Background. Ocular lymphoma is an uncommon cause of chronic vitreitis or uveitis, often refractory to steroid treatment, and frequently repr esenting another site of multifocal primary central nervous system lym phoma (PCNSL). Methods. The authors reviewed the medical and ophthalmo logic records of 24 patients with ocular lymphoma; 23 had associated P CNSL. Results. In half, the eyes were the initial site of disease; in the others central nervous system (CNS) lymphoma developed before, or concurrent with, ocular lymphoma. Most patients had bilateral ocular s ymptoms; slit-lamp examination revealed asymptomatic disease in four. Vitrectomy was not always diagnostic, particularly in patients who had received steroids. Ocular ultrasound, performed on seven patients, pr ovided an objective measure of disease and treatment response. Patient s received a variety of therapeutic combinations of steroids, radiatio n, and chemotherapy, including high-dose cytosine arabinoside. Despite therapy, eventual ocular or CNS relapse or both was common. Thirteen patients have died, 12 with known recurrent CNS disease. Conclusions. Ocular lymphoma frequently is associated with PCNSL. The diagnosis sho uld be considered in patients with steroid-resistant chronic vitreitis or uveitis. Patients with PCNSL should be carefully evaluated for ocu lar involvement, regardless of symptoms. Treatment can contribute to p rolonged remission, but eventual ocular or CNS relapse is the rule.